Skip to content

Evaluation of the utility of cardio-pulse wave examination device

Evaluation of the utility of cardio-pulse wave examination device for the atherosclerosis disease - CPWE study

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs032180046
Enrollment
50
Registered
2018-11-29
Start date
2018-12-06
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral and cervical arteriosclerosis, ischemic heart disease, obstructive atherosclerosis,diabetes

Interventions

Measurement using by the atherosclerosis degree measuring device
Cardio-pulse wave examination device, PWV (pulse wave velocity)

Sponsors

Matsumura Akira
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients satisfying all of the following criteria are subject to this clinical trial. 1. Patients with arteriosclerotic diseases of cerebral artery / carotid arteriosclerosis, coronary arteriosclerosis, and arteriosclerosis obliterans. 2. Patients clinically diagnosed with arteriosclerosis by image inspection such as blood pressure, blood test, echo, CT, MRI, etc., or patients suspected. 3. Patient who can consent document by himself / herself. If writing is difficult due to hemiplegia or the like, put a substitute writer. If consent by the person himself / herself is difficult due to aphasia or the like, put a substitute person. 4. Patient who is over 20 years of age at consent acquisition.

Exclusion criteria

Exclusion criteria: Patients who conflict with one of the following criteria are excluded and not subject to this clinical study. 1. Patients who cannot wear device due to amputation of both lower leg. 2. Patients using active implantable medical devices such as cardiac pacemakers. 3. Patients who judged that medical doctor is inappropriate for participation in this study. 4. Patients with severe consciousness disturbance. 5. Diseases and postoperative patients who may have an adverse effect on the evaluation of this device such as circulatory insufficiency such as shock, chronic atrial fibrillation, vasculitis, artificial blood vessel replacement surgery, stent graft interpolation, etc.

Design outcomes

Primary

MeasureTime frame
PWV (Pulse Wave Velocity)

Secondary

MeasureTime frame
ABI (Ankle brachial pressure index), CAVI (Cardio-ankle vascular index), arterial stenosis rate, arterial blood flow velocity, arterial intimal hyperplasia, blood pressure, HbA1c, LDL-cho, TG, HDL-cho, smoking index.

Contacts

Public ContactAiki Marushima

University of Tsukuba Hospital

aiki.marushima@md.tsukuba.ac.jp+81-29-853-3220

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026